2 results match your criteria: "The First Affiliated Hospital of Zhengzhou UniversityHenan[Affiliation]"
Am J Transl Res
November 2017
Department of Pathology, The First Affiliated Hospital of Zhengzhou UniversityHenan, China.
This study aimed to investigate whether tumor-associated macrophages (TAMs) and esophageal squamous cell carcinoma (ESCC) cells could synergistically influence the generation of lymphatic vessels via the VEGF-C/VEGFR-3 signaling pathway and to address its mechanism. M2 macrophages were sorted with immunomagnetic beads and induced . VEGF-C siRNA plasmids were constructed and transfected into M2 macrophages and the ESCC cell line KYSE150.
View Article and Find Full Text PDFFront Pharmacol
September 2016
Institute of Clinical Pharmacology, Zhengzhou University Henan, China.
Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate (BZP) is a potential cardiovascular drug and exerts potent neuroprotective effect against transient and long-term ischemic stroke in rats. BZP could convert into 3-butyl-6-bromo-1(3H)-isobenzofuranone (Br-NBP) in vitro and in vivo. However, the pharmacokinetic profiles of BZP and Br-NBP still have not been evaluated.
View Article and Find Full Text PDF